Obesity, Morbid: Clinical Trials

931 trials for Obesity, Morbid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

517 completed, 173 unknown, 93 recruiting, 41 terminated. 487 Not applicable, 57 Phase 4, 31 Phase 2, 30 Phase 3, 16 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable487Completed 269, Unknown 94, Recruiting 37, Active not recruiting 26, Terminated 26, Withdrawn 14, Not yet recruiting 13, Enrolling by invitation 7, Suspended 1
Phase 457Completed 33, Unknown 9, Not yet recruiting 6, Recruiting 5, Active not recruiting 2, Withdrawn 2
Phase 231Completed 18, Unknown 9, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 330Completed 15, Unknown 10, Recruiting 2, Terminated 2, Active not recruiting 1
Phase 116Completed 10, Unknown 5, Withdrawn 1
Early Phase 16Completed 2, Unknown 2, Recruiting 1, Suspended 1

Follow Obesity, Morbid: new trials by email Literature Review of Obesity, Morbid trials Research Report on Obesity, Morbid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Study of an Explainable AI Tool to Support Biliopancreatic Limb Selection in One-Anastomosis Gastric Bypass
One-anastomosis gastric bypass with observed biliopancreatic limb length - Obesity, Severe Obesity
Not yet recruitingThe Society of Bariatric and Metabolic Surgeons of Kazakhstan1202027-01-152026-09-14
Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Evaluating Metabolic Health in Individuals With Extreme Obesity
High-fat test meal - BMI>40
Not yet recruitingPennington Biomedical Research Center102026-10-012026-09-17
Inhaled Nitric Oxide in Severe Obesity
Nitric oxide - Obesity, Respiratory Insufficiency
Not applicableNot yet recruitingMassachusetts General Hospital602026-10-012026-05-20
Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)
Semaglutide weekly injection, Placabo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1042026-10-012026-10-05
Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery
Semaglutide weekly injection, Placebo - Morbid Obesity
Phase 4Not yet recruitingGeneral Committee of Teaching Hospitals and Institutes, Egypt1002026-10-012026-10-05
Continuous Glucose Monitoring in Metabolic Surgery
Abbot Freestyle Libre CGM - Obesity (Disorder)
Not applicableNot yet recruitingPennington Biomedical Research Center202026-09-202026-09-15
Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery
Sleeve Gastrectomy - Obesity, Morbid
Not yet recruitingLaval University1502026-09-012026-07-16
Endoscopic Sleeve Gastroplasty Technique Comparison for Weight Loss
Endoscopic Sleeve Gastroplasty - Belt and Suspenders, Endoscopic Sleeve Gastroplasty - Belt - Obesity, Obesity, Morbid
Not applicableNot yet recruitingBrigham and Women's Hospital102026-09-012025-12-02
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Prophylactic mesh - Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruitingAesculap AG1102026-09-012026-06-02
Impact of MBS on Body Composition, Basal Metabolic Rates and Muscle Functions in Morbid Obese Patients
Obesity, Morbid, Obesity; Endocrine
Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar212026-09-012026-07-30
Videolaryngoscopes in the Morbidly Obese
Airway management - Obesity Difficult Airway Airway Management
Not applicableEnrolling by invitationUniwersytet Radomski im. Kazimierza Pułaskiego1002026-08-152026-08-26
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
GLP-1 receptor agonist therapy - Morbid Obesity, Anorectal Diseases
Not yet recruitingGazi University1002026-08-012026-06-25
Glycemic Variability After SASI Versus Roux-en-Y Gastric Bypass
Single Anastomosis Sleeve Ileal Bypass, Roux-en-Y Gastric Bypass - Obesity, Morbid
Not applicableRecruitingHospitales Universitarios Virgen del Rocío682026-07-142026-10-13
Evaluation of Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms After Bariatric Surgery in Body Weight Management
Clinical and Biochemical Assessment - Obesity, Morbid, Bariatric Surgery
Not yet recruitingToros University402026-07-012026-06-11
Impact of Bariatric Surgery on Female Sexual Function and Sex Hormones
Sleeve Gastrectomy, Gastric Bypass - Morbid Obesity
RecruitingCairo University402026-06-052026-06-10
Investigation of the Effects of Whole Body Vibration Application on Muscle Functional Level, Physical Fitness and Respiratory Parameters After Bariatric Surgery
Resistance Training, Whole Body Vibration, Control Group - Obesity & Overweight, Morbid Obesity
Not applicableNot yet recruitingKirsehir Ahi Evran Universitesi602026-05-302026-05-22
High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea
High-Intensity Progressive Inspiratory Muscle Training (IMT) - Obesity, Class III, Sleep Apnea, Obstructive
Not applicableNot yet recruitingUniversity of the State of Santa Catarina102026-05-012026-03-23

Showing 20 of 931. Sign in to see all of them.

Narrower conditions

Obesity (258)  ·  Weight Loss (82)  ·  Diabetes Mellitus, Type 2 (39)  ·  Metabolic Syndrome (33)  ·  Diabetes Mellitus (27)  ·  Non-alcoholic Fatty Liver Disease (26)  ·  Motor Activity (24)  ·  Insulin Resistance (23)  ·  Gastroesophageal Reflux (22)  ·  Hypertension (19)  ·  Pain, Postoperative (19)  ·  Overweight (17)  ·  Postoperative Complications (13)  ·  Sleep Apnea, Obstructive (13)

Broader conditions

Nutritional and Metabolic Diseases (931)  ·  Signs and Symptoms (931)  ·  Overnutrition (930)  ·  Nutrition Disorders (929)  ·  Pathological Conditions, Signs and Symptoms (928)  ·  Body Weight (924)  ·  Overweight (914)  ·  Obesity (673)  ·  Metabolic Diseases (112)  ·  Glucose Metabolism Disorders (107)  ·  Body Weight Changes (90)  ·  Digestive System Diseases (79)  ·  Pathologic Processes (78)  ·  Endocrine System Diseases (70)  ·  Behavior (52)

Interventions

Bariatric Surgery (55)  ·  Gastric Bypass (50)  ·  Acetaminophen (8)  ·  Exercise (8)  ·  Surgical Procedures, Operative (8)  ·  Propofol (7)  ·  Saline Solution (7)  ·  Control Groups (6)  ·  Diet (6)  ·  Liraglutide (6)  ·  Fentanyl (5)  ·  Ketamine (5)  ·  Surveys and Questionnaires (5)  ·  Bupivacaine (4)  ·  Caloric Restriction (4)

Sponsors

Norwegian University of Science and Technology (33)  ·  Minia University (18)  ·  Mansoura University (17)  ·  Assistance Publique - Hôpitaux de Paris (13)  ·  Rijnstate Hospital (11)  ·  IHU Strasbourg (10)  ·  Hvidovre University Hospital (9)  ·  Inonu University (9)  ·  Laval University (9)  ·  Ain Shams University (8)  ·  Fatih Sultan Mehmet Training and Research Hospital (8)  ·  University of Foggia (8)  ·  General Committee of Teaching Hospitals and Institutes, Egypt (7)  ·  Johns Hopkins University (7)  ·  Sheba Medical Center (7)

Countries

United States (210)  ·  Egypt (73)  ·  Turkey (Türkiye) (70)  ·  France (64)  ·  Italy (54)  ·  Norway (51)  ·  Brazil (37)  ·  Spain (37)  ·  Canada (32)  ·  Netherlands (31)  ·  Israel (23)  ·  Germany (20)  ·  Sweden (16)  ·  Switzerland (15)  ·  Denmark (12)

Top investigators

Johannes Hebebrand, Prof. Dr. med. (6)  ·  Martin Wabitsch, Prof. Dr. med. (5)  ·  Susanna Wiegand, Dr. med. (5)  ·  Thomas Reinehr, Prof. Dr. med. (5)  ·  Wieland Kiess, Prof. Dr. med. (5)  ·  Christopher C. Thompson, MD, MSc (4)  ·  John P Cello, MD (4)  ·  Reinhard Holl, Prof. Dr. med. (4)  ·  Andrei Keidar, MD (3)  ·  Geltrude Mingrone, MD, PhD (3)  ·  Jennifer McNulty, MD (3)  ·  Laurent Biertho, MD (3)  ·  Sameh H Emile, M.D. (3)

Results publications

PMID 23987123, PMID 37652841, PMID 20010088, PMID 21823370, PMID 22963820, PMID 24527718, PMID 30247434, PMID 32328827, PMID 35432994, PMID 38055284, PMID 39819027, PMID 40854969, PMID 41077621, PMID 10022413, PMID 10340809, PMID 10422935, PMID 10592173, PMID 10604470, PMID 10781266, PMID 10856276, PMID 11270007, PMID 11410823, PMID 11435250, PMID 11460821, PMID 11472277, PMID 11506296, PMID 11549535, PMID 11687509, PMID 11733397, PMID 11748392, PMID 11779730, PMID 11867407, PMID 11867408, PMID 11981209, PMID 11997813, PMID 12063573, PMID 12075174, PMID 12194550, PMID 12456460, PMID 12540590, PMID 12559191, PMID 12796570, PMID 1387700, PMID 14674978, PMID 14691697, PMID 14750005, PMID 15082974, PMID 15105237, PMID 1519574, PMID 15256293

NIH funding

2009 (2), 2019 (2), 2023 (2), 1IK2CX000549-01 (1), 2014 (1), 2017 (1), 2025 (1), K12TR004413 (1), P30DK048520 (1), R01CA268034 (1), R01DK067561 (1), R01DK072526 (1), R01DK077102 (1), R01DK095128 (1), R01DK098492 (1)